Increased plasma interleukin-6 concentrations in alcoholic hepatitis - PubMed (original) (raw)
. 1992 May;119(5):547-52.
Affiliations
- PMID: 1583411
Increased plasma interleukin-6 concentrations in alcoholic hepatitis
D B Hill et al. J Lab Clin Med. 1992 May.
Abstract
Interleukin-6 (hepatocyte stimulating factor) is a 26 kd cytokine that plays a major role in the acute phase response, especially the hepatic aspects of the acute phase response. Patients with alcoholic hepatitis manifest many aspects of the acute phase response. In this 6-month study we evaluated serial plasma interleukin-6 levels in 30 consecutive patients with moderate to severe alcoholic hepatitis. Mean admission plasma interleukin-6 activity was markedly increased (49.8 +/- 8.5 U/ml, normal less than 5 U/ml) in patients with alcoholic hepatitis, and levels decreased with clinical improvement to 15.6 +/- 6.1 U/ml at 6 months. Admission interleukin-6 activity correlated significantly (r = 0.82) with the severity of liver disease as assessed by the discriminant function of Maddrey. Also measured were selected assays postulated to be regulated by interleukin-6, including serum albumin (2.3 +/- 0.1 gm/dl), which was significantly depressed; alpha 1-acid glycoprotein (52 +/- 5 mg/dl), which was within normal limits; and IgA (827 +/- 70 mg/dl) and C-reactive protein (3.03 +/- 0.51 mg/dl), which were significantly elevated. Interleukin-6 activity fell over time in a pattern similar to that of bilirubin and C-reactive protein. We suggest that plasma interleukin-6 may not only regulate many aspects of the acute phase response but also may be a marker of inflammation and severity of disease in alcoholic hepatitis.
Similar articles
- Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H. Fujimoto M, et al. Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S. Alcohol Clin Exp Res. 2000. PMID: 10803780 - Increased plasma interleukin-8 concentrations in alcoholic hepatitis.
Hill DB, Marsano LS, McClain CJ. Hill DB, et al. Hepatology. 1993 Sep;18(3):576-80. Hepatology. 1993. PMID: 8359798 - Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.
Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Khoruts A, et al. Hepatology. 1991 Feb;13(2):267-76. Hepatology. 1991. PMID: 1995437 - Interleukin-8 in alcoholic liver disease.
Bird G. Bird G. Acta Gastroenterol Belg. 1994 May-Aug;57(3-4):255-9. Acta Gastroenterol Belg. 1994. PMID: 7810274 Review. - New Prospects for Medical Management of Acute Alcoholic Hepatitis.
Liu M, Shah VH. Liu M, et al. Clin Liver Dis (Hoboken). 2019 May 31;13(5):131-135. doi: 10.1002/cld.792. eCollection 2019 May. Clin Liver Dis (Hoboken). 2019. PMID: 31236260 Free PMC article. Review. No abstract available.
Cited by
- Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD).
Sánchez V, Baumann A, Kromm F, Yergaliyev T, Brandt A, Scholda J, Kopp F, Camarinha-Silva A, Bergheim I. Sánchez V, et al. Mol Med. 2024 Oct 18;30(1):181. doi: 10.1186/s10020-024-00950-4. Mol Med. 2024. PMID: 39425011 Free PMC article. - Patterns of IgA Autoantibody Generation, Inflammatory Responses and Extracellular Matrix Metabolism in Patients with Alcohol Use Disorder.
Niemelä O, Bloigu A, Bloigu R, Nivukoski U, Kultti J, Pohjasniemi H. Niemelä O, et al. Int J Mol Sci. 2023 Aug 23;24(17):13124. doi: 10.3390/ijms241713124. Int J Mol Sci. 2023. PMID: 37685930 Free PMC article. - Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway.
Wu S, Wen F, Zhong X, Du W, Chen M, Wang J. Wu S, et al. Ann Med. 2023 Dec;55(1):2216942. doi: 10.1080/07853890.2023.2216942. Ann Med. 2023. PMID: 37243569 Free PMC article. - Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.
Neri AA, Dontas IA, Iliopoulos DC, Karatzas T. Neri AA, et al. In Vivo. 2020 May-Jun;34(3):953-964. doi: 10.21873/invivo.11863. In Vivo. 2020. PMID: 32354880 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous